EBITDA Summary of Cardinal Health, Inc.

Cardinal Health, Inc.'s latest annual EBITDA in 2024 was 1.97 Billion USD , up 37.27% from previous year.
Cardinal Health, Inc.'s latest quarterly EBITDA in 2024 FY was N/A , down -49.59% from previous quarter.
Cardinal Health, Inc. reported an annual EBITDA of 1.44 Billion USD in 2023, up 5.38% from previous year.
Cardinal Health, Inc. reported an annual EBITDA of 126 Million USD in 2022, down -10.82% from previous year.
Cardinal Health, Inc. reported a quarterly EBITDA of N/A for 2024 FY, down -49.59% from previous quarter.
Cardinal Health, Inc. reported a quarterly EBITDA of 681 Million USD for 2024 Q1, down -50.62% from previous quarter.

Annual EBITDA Chart of Cardinal Health, Inc. (2024 - 1989)

Historical Annual EBITDA of Cardinal Health, Inc. (2024 - 1989)

Year	EBITDA	EBITDA Growth
2024	1.97 Billion USD	37.27%
2023	1.44 Billion USD	5.38%
2022	126 Million USD	-10.82%
2021	1.31 Billion USD	-2.31%
2020	-2.61 Billion USD	-1.18%
2019	3.03 Billion USD	-5.85%
2018	1.12 Billion USD	-2.6%
2017	2.83 Billion USD	-3.52%
2016	3.08 Billion USD	15.97%
2015	2.55 Billion USD	9.69%
2014	2.39 Billion USD	5.0%
2013	2.3 Billion USD	6.63%
2012	2.11 Billion USD	14.7%
2011	1.92 Billion USD	4.23%
2010	1.57 Billion USD	-27.47%
2009	2.26 Billion USD	-6.71%
2008	2.66 Billion USD	1.51%
2007	1.69 Billion USD	2.55%
2006	2.14 Billion USD	-8.73%
2005	2.2 Billion USD	2.48%
2004	2.69 Billion USD	4.45%
2003	2.59 Billion USD	18.33%
2002	2.2 Billion USD	17.08%
2001	1.76 Billion USD	20.52%
2000	1.53 Billion USD	10.42%
1999	1.28 Billion USD	142.56%
1998	1.07 Billion USD	18.76%
1997	924.8 Million USD	33.22%
1996	333.3 Million USD	102.85%
1995	285.3 Million USD	82.52%
1994	103 Million USD	72.88%
1993	66.2 Million USD	21.64%
1992	53 Million USD	36.78%
1991	39.3 Million USD	40.86%
1990	27.9 Million USD	32.86%
1989	21 Million USD	40.0%

Year	EBITDA	EBITDA Growth
2024 Q3	778 Million USD	-17.68%
2024 FY	- USD	-49.59%
2024 Q1	681 Million USD	-50.62%
2024 Q4	718 Million USD	6.5%
2024 Q2	691 Million USD	320.63%
2023 FY	- USD	5.38%
2023 Q1	515 Million USD	0.59%
2023 Q2	578 Million USD	12.23%
2023 Q4	666 Million USD	-5.8%
2023 Q3	707 Million USD	22.32%
2022 Q4	512 Million USD	-20.5%
2022 Q2	563 Million USD	-9.34%
2022 Q1	621 Million USD	42.43%
2022 Q3	644 Million USD	14.39%
2022 FY	- USD	-10.82%
2021 Q3	792 Million USD	9.39%
2021 Q4	436 Million USD	-44.95%
2021 FY	- USD	-2.31%
2021 Q1	654 Million USD	14.54%
2021 Q2	724 Million USD	10.7%
2020 Q2	660 Million USD	0.0%
2020 Q3	797 Million USD	20.76%
2020 FY	- USD	-1.18%
2020 Q4	571 Million USD	-28.36%
2020 Q1	660 Million USD	11.49%
2019 Q4	592 Million USD	-24.78%
2019 Q1	598 Million USD	14.12%
2019 FY	- USD	-5.85%
2019 Q2	741 Million USD	23.91%
2019 Q3	787 Million USD	6.21%
2018 Q2	842 Million USD	28.75%
2018 Q1	654 Million USD	-2.68%
2018 Q3	867 Million USD	2.97%
2018 Q4	524 Million USD	-39.56%
2018 FY	- USD	-2.6%
2017 FY	- USD	-3.52%
2017 Q3	831 Million USD	12.91%
2017 Q4	672 Million USD	-19.13%
2017 Q2	736 Million USD	1.66%
2017 Q1	724 Million USD	-2.03%
2016 Q4	739 Million USD	-10.53%
2016 Q2	744 Million USD	-2.23%
2016 FY	- USD	15.97%
2016 Q1	761 Million USD	19.65%
2016 Q3	826 Million USD	11.02%
2015 FY	- USD	9.69%
2015 Q4	636 Million USD	-8.75%
2015 Q3	697 Million USD	0.72%
2015 Q2	692 Million USD	10.9%
2015 Q1	624 Million USD	20.93%
2014 Q3	648 Million USD	0.31%
2014 Q4	516 Million USD	-20.37%
2014 Q1	604 Million USD	11.85%
2014 FY	- USD	5.0%
2014 Q2	646 Million USD	6.95%
2013 Q2	592 Million USD	10.24%
2013 FY	- USD	6.63%
2013 Q4	540 Million USD	-14.42%
2013 Q3	631 Million USD	6.59%
2013 Q1	537 Million USD	7.83%
2012 FY	- USD	14.7%
2012 Q4	498 Million USD	-18.02%
2012 Q3	607.5 Million USD	10.11%
2012 Q2	551.7 Million USD	-0.07%
2012 Q1	552.1 Million USD	37.44%
2011 FY	- USD	4.23%
2011 Q4	401.7 Million USD	-27.6%
2011 Q3	554.8 Million USD	26.26%
2011 Q2	439.4 Million USD	22.02%
2011 Q1	360.1 Million USD	-8.77%
2010 Q4	394.7 Million USD	-17.11%
2010 Q1	441.8 Million USD	-25.84%
2010 FY	- USD	-27.47%
2010 Q2	474.1 Million USD	7.31%
2010 Q3	476.2 Million USD	0.44%
2009 Q4	595.7 Million USD	-7.56%
2009 FY	- USD	-6.71%
2009 Q1	633 Million USD	-3.45%
2009 Q2	684 Million USD	8.06%
2009 Q3	644.4 Million USD	-5.79%
2008 Q3	719.2 Million USD	8.28%
2008 Q4	655.6 Million USD	-8.84%
2008 FY	- USD	1.51%
2008 Q1	627.2 Million USD	-13.18%
2008 Q2	664.2 Million USD	5.9%
2007 FY	- USD	2.55%
2007 Q4	722.4 Million USD	3.64%
2007 Q3	697 Million USD	13.41%
2007 Q2	614.6 Million USD	0.47%
2007 Q1	611.7 Million USD	-10.88%
2006 Q4	686.4 Million USD	-4.23%
2006 FY	- USD	-8.73%
2006 Q3	716.7 Million USD	13.65%
2006 Q2	630.6 Million USD	21.83%
2006 Q1	517.6 Million USD	-34.13%
2005 Q2	715.7 Million USD	47.29%
2005 FY	- USD	2.48%
2005 Q1	485.9 Million USD	-30.82%
2005 Q4	785.8 Million USD	0.41%
2005 Q3	782.6 Million USD	9.35%
2004 Q3	757.2 Million USD	15.02%
2004 Q1	604.3 Million USD	-16.07%
2004 FY	- USD	4.45%
2004 Q4	702.4 Million USD	-7.24%
2004 Q2	658.3 Million USD	8.94%
2003 FY	- USD	18.33%
2003 Q4	671 Million USD	4.85%
2003 Q3	676.9 Million USD	11.19%
2003 Q2	655.2 Million USD	12.62%
2003 Q1	529.7 Million USD	-9.07%
2002 Q1	461.2 Million USD	-8.4%
2002 FY	- USD	17.08%
2002 Q3	551.8 Million USD	7.75%
2002 Q4	532.7 Million USD	2.06%
2002 Q2	531.6 Million USD	15.82%
2001 Q1	388.5 Million USD	-4.49%
2001 FY	- USD	20.52%
2001 Q4	498.6 Million USD	0.47%
2001 Q3	428.2 Million USD	17.65%
2001 Q2	430.3 Million USD	11.67%
2000 Q2	370.2 Million USD	3.33%
2000 FY	- USD	10.42%
2000 Q4	398.3 Million USD	-2.98%
2000 Q3	429.1 Million USD	12.48%
2000 Q1	325.2 Million USD	-3.83%
1999 FY	- USD	142.56%
1999 Q4	350.1 Million USD	-22.74%
1999 Q3	403.2 Million USD	116.45%
1999 Q2	310.4 Million USD	27.52%
1999 Q1	277.2 Million USD	3.99%
1998 Q1	120.5 Million USD	-17.26%
1998 Q2	180.9 Million USD	30.54%
1998 Q3	341.2 Million USD	41.39%
1998 Q4	148.8 Million USD	-6.88%
1998 FY	- USD	18.76%
1997 Q1	79.1 Million USD	-56.68%
1997 Q4	120.5 Million USD	-29.92%
1997 FY	- USD	33.22%
1997 Q3	132.3 Million USD	43.66%
1997 Q2	113.3 Million USD	55.69%
1996 Q3	73.6 Million USD	-2.16%
1996 Q4	132.3 Million USD	143.59%
1996 Q1	44.3 Million USD	-13.94%
1996 Q2	59.9 Million USD	71.53%
1996 FY	- USD	102.85%
1995 Q3	55.3 Million USD	29.76%
1995 Q2	43.8 Million USD	16.67%
1995 Q1	36.4 Million USD	203.15%
1995 FY	- USD	82.52%
1995 Q4	49.5 Million USD	-7.89%
1994 Q2	21 Million USD	14.94%
1994 Q3	41 Million USD	282.0%
1994 Q4	1.2 Million USD	-145.68%
1994 FY	- USD	72.88%
1994 Q1	18.6 Million USD	10.83%
1993 Q3	20.9 Million USD	37.24%
1993 Q4	16.7 Million USD	-21.11%
1993 FY	- USD	21.64%
1993 Q1	14.3 Million USD	-104.93%
1993 Q2	16 Million USD	2171.43%
1992 Q2	13.9 Million USD	44.32%
1992 FY	- USD	36.78%
1992 Q1	10.6 Million USD	4.76%
1992 Q4	14.9 Million USD	-19.32%
1992 Q3	18.3 Million USD	38.58%
1991 FY	- USD	34.36%
1991 Q2	10.4 Million USD	12.5%
1991 Q3	12.9 Million USD	27.78%
1991 Q4	10.1 Million USD	-26.96%
1991 Q1	9 Million USD	26.98%
1990 Q1	210.2 Million USD	3.39%
1990 FY	- USD	35.6%
1990 Q4	7 Million USD	-25.88%
1990 Q2	6.8 Million USD	-97.05%
1990 Q3	9 Million USD	37.1%
1989 Q4	203.3 Million USD	142.0%
1989 Q2	182.8 Million USD	11.19%
1989 Q1	164.4 Million USD	6.06%
1989 Q3	-484 Million USD	-364.77%
1989 FY	- USD	36.43%

Peer EBITDA Comparison of Cardinal Health, Inc.

Name	EBITDA	EBITDA Difference
Cencora	3.25 Billion USD	39.193%
McKesson Corporation	4.66 Billion USD	57.617%
Owens & Minor, Inc.	400.28 Million USD	-394.147%
Prestige Consumer Healthcare Inc.	373.1 Million USD	-430.147%

Global Stocks Search

Cardinal Health, Inc. (CAH)

EBITDA Summary of Cardinal Health, Inc.

Annual EBITDA Chart of Cardinal Health, Inc. (2024 - 1989)

Historical Annual EBITDA of Cardinal Health, Inc. (2024 - 1989)

Peer EBITDA Comparison of Cardinal Health, Inc.